Ablynx's revenues double and losses narrow
11 May 2009
Sita Shah
Please Login to read the full article.
11 May 2009
Sita Shah
sita.shah@informa.com
Ablynx's net loss narrowed by 9% to €3 million in the first quarter of 2009, as it controlled its cash burn and expenses. Meanwhile, its revenues more than doubled to €7.5 million.
Analysts say that the Belgian company is on track to meet revenues of around €15 million in the...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Immunomedics, UCB restructure Phase III candidate epratuzumab licence agreement
- Pfizer's Russian effect sends arthritis drug back to Ablynx to confirm 8-week dosing
- Pfizer on schedule to consolidate Enbrel franchise as ozoralizumab hits RA endpoint
- Abbott outlines pharma growth strategies
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
